Canine GM-CSF ELISA kit (NR-E30007)
search
  • Canine GM-CSF ELISA kit (NR-E30007)

Canine GM-CSF ELISA kit

Catalog # NR-E30007

Print

$756.00
Quantity

For research use only. Not for diagnostic or therapeutic use, or for human or veterinary use. Sold only to research institutions and qualified laboratory professionals. Not for sale to individuals for personal use.

Assay Range

156-10000 pg/mL

Sensitivity

10 pg/mL

Specificity

No cross-reaction with other related substances detected

Size

96T

Storage

Store at 2 - 8ºC. Keep reconstituted standard and detection Ab at -20 ºC

Assay Principle

Sandwich ELISA

Sample Volume

100 µL final volume, dilution factor varies on samples

Sample Type

Cell culture supernatants.

Detection Method

Chromogenic

 

 

Kit Components

 

 1. Recombinant Canine  GM-CSF standard: 2 vials

 2. One 96-well plate coated with Canine GM-CSF  Ab

 3. Sample diluent buffer: 12 mL - 1

 4. Detection antibody: 1 vial

 5. Streptavidin-HRP: 1 vial

 6. Antibody diluent buffer:12 mL x1  

 7. Streptavidin-HRP diluent buffer: 12 mL x1

 8. Chromogenic solution  A:  6 mlx1

 9. Chromogenic solution  B: 6 mlx1

10. Stop solution:  6 mL x1

11. Washing solution (20x):  25 mL x1

 

Background     

Granulocyte-macrophage colony-stimulating factor (GM-CSF), also known as colony stimulating factor 2 (CSF2), is a cytokine belonging to the GM-CSF family. GM-CSF is secreted by a variety of cell types including macrophages, T cells, mast cells, endothelial cells and fibroblasts. GM-CSF stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes. GM-CSF exerts its biological effects through a heterodimeric receptor complex composed of GM-CSF Rα/CD116 and the signal transducing common β chain (CD131) which is also a component of the high affinity receptors for IL3 and IL5. As an important modulator of the immune/inflammatory cascade, GM-CSF promotes Th1 biased immune response, angiogenesis, allergic inflammation, and the development of autoimmunity. GM-CSF has been manufactured by recombinant DNA technology and marketed as a protein therapeutic reagent to stimulate the production of white blood cells and thus prevent neutropenia following chemotherapy.

New